Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc.

Biotechnology

US, Chicago [HQ]

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Competitors · Subsidiaries · Locations

Business Intelligence

Competitors · Subsidiaries · Locations · Network

This feature shows the market relationships of Cardio Diagnostics Holdings, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices, fabrics and competitors around the globe.

Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.

U.S. · Business Intelligence

The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.

Worldwide · Business Intelligence

The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.

Worldwide · Competitors Table

Sourced from FMP or manual.

Competitor	Source	Accuracy	Country	City
Phio Pharmaceuticals Corp.	FMP	High	United States	Marlborough
Immix Biopharma, Inc.	FMP	High	United States	Los Angeles
Sonnet BioTherapeutics Holdings, Inc.	FMP	High	United States	Princeton
Pyxis Oncology, Inc.	FMP	High	United States	Cambridge
ZyVersa Therapeutics, Inc.	FMP	High	United States	Weston
CNS Pharmaceuticals, Inc.	FMP	High	United States	Houston
Elevation Oncology, Inc.	FMP	High	United States	New York
Zura Bio Limited	FMP	High	United States	San Diego
eFFECTOR Therapeutics, Inc.	FMP	High	United States	Solana Beach
180 Life Sciences Corp.	FMP	High	United States	Palo Alto
AVROBIO, Inc.	FMP	High	United States	Cambridge

Worldwide · Subsidiaries Table

Sourced from the SEC, through government awards and manual entries.

Subsidiary	Private?	Country	City
-	-	-	-